Home > > > Defibrillator Market Forecast to 2034: North America Leads as Asia Pacific Accelerates

Defibrillator Market Forecast to 2034: North America Leads as Asia Pacific Accelerates

Author : savi ssd | Published On : 30 Sep 2026

The global defibrillator market was valued at USD 15.18 billion in 2025 and is projected to grow from USD 16.21 billion in 2026 to USD 27.46 billion by 2034, registering a 6.81% CAGR during 2026–2034. North America dominated the market with a 38.6% share in 2025, while Asia Pacific is projected to be the fastest-growing region at an 8.91% CAGR during the forecast period.

  • Market Size (2025): USD 15.18 Billion

  • Market Size (2026): USD 16.21 Billion

  • CAGR (Forecast Period): 6.81% (2026–2034)

  • Forecast Year: 2034

  • Projected Market Size (2034): USD 27.46 Billion

  • Dominant Region: North America – 38.6% market share

  • Fastest Growing Region: Asia Pacific – 8.91% CAGR

Market Overview

Defibrillators are medical devices that deliver controlled electrical shocks to help restore normal heart rhythm during life-threatening cardiac conditions such as sudden cardiac arrest. The market includes implantable cardioverter-defibrillators, external defibrillators, automated external defibrillators, and emerging wearable systems used across hospitals, emergency services, public spaces, and home-care settings. Connected monitoring and wearable technologies are broadening the role of defibrillation beyond traditional clinical environments.

Growth Drivers

Expansion of cardiac-care infrastructure is increasing the need for defibrillators across emergency departments, intensive-care units, cardiac-care facilities, and emergency medical services. Broader access to specialized cardiac services creates additional procurement requirements for rapid rhythm management and resuscitation equipment. Advances in battery and power-management technologies are also supporting portable AEDs and transport defibrillators by improving operating reliability and reducing device downtime.

Market Challenges

Product recalls and reliability concerns can disrupt procurement and increase corrective-action requirements for manufacturers. A 2025 FDA Class II recall involving ZOLL Powerheart G5 AEDs illustrates how device issues can require market corrections and affect confidence among healthcare providers. Connected defibrillators also face cybersecurity requirements, with FDA guidance in 2026 placing additional design and premarket-submission requirements on qualifying cyber devices.

Market Opportunities

Public-access defibrillation programs offer opportunities for manufacturers, community organizations, schools, workplaces, sports facilities, and AED providers to expand access to emergency cardiac equipment. Service-based models can add recurring revenue through maintenance, compliance monitoring, program management, and training. ZOLL's Rescue Ready Services and PlusTrac platform demonstrate how software and support services can complement AED deployment.

Segment Analysis

By product, the implantable cardioverter-defibrillators (ICDs) segment accounted for a 61.7% share in 2025, supported by their established role in preventing sudden cardiac death, continuously monitoring cardiac rhythms, and delivering immediate therapy for life-threatening ventricular arrhythmias. The external defibrillators segment is expected to grow at a 7.58% CAGR during 2026–2034, supported by use across hospitals, emergency care, ambulances, and public-access settings.

By end user, the hospital segment accounted for a 46.2% share in 2025, owing to specialized cardiac-care facilities, trained medical professionals, emergency-response capabilities, and established use of defibrillators for managing life-threatening arrhythmias. The home healthcare segment is expected to grow at a 8.73% CAGR during 2026–2034, fueled by accessible cardiac care, portable defibrillation devices, and greater emphasis on timely emergency response outside hospitals.

Regional Analysis

North America dominated the defibrillator market with a 38.6% share in 2025. Established emergency-care networks, extensive hospital infrastructure, and deployment of advanced cardiac-resuscitation technologies continue to support the region. In the U.S., public-access defibrillation initiatives are encouraging wider AED availability, while Canada's substantial out-of-hospital cardiac-arrest burden supports continued focus on early defibrillation.

Asia Pacific is the fastest-growing regional market, projected to register an 8.91% CAGR during 2026–2034. Expanding hospital networks, improving healthcare accessibility, and adoption of advanced cardiac-care technologies are broadening defibrillator use across urban and emerging healthcare settings. China, Japan, South Korea, and India remain important markets within the region.

Europe accounted for 27.4% of the global market in 2025 and is projected to grow at a 6.58% CAGR during 2026–2034. Public-access defibrillation programs, emergency-response networks, and initiatives supporting AED availability are contributing to regional development, with the U.K., Germany, and France representing key markets.

Competitive Landscape

The defibrillator market is moderately fragmented, with medical device manufacturers, cardiovascular technology companies, emergency-care equipment providers, and specialized defibrillator developers competing across hospital, emergency medical services, public-access, and wearable applications. Competition centers on device reliability, clinical performance, safety, connectivity, monitoring capabilities, regulatory compliance, and distribution networks. Key companies include:

  • Stryker Corporation

  • Asahi Kasei Corporation

  • Abbott

  • BIOTRONIK SE & Co. KG

  • Medtronic plc

  • Cardiac Science Corporation

  • Boston Scientific Corporation

  • Philips Healthcare

  • LivaNova PLC

  • Nihon Kohden Corporation

  • Koninklijke Philips N.V.

  • Schiller AG

Recent Developments

In June 2026, Philips advanced its emergency-care solutions portfolio with automated external defibrillator technologies focused on connectivity, monitoring, and user guidance. In May 2026, Stryker advanced its LIFEPAK defibrillator technologies with initiatives focused on device reliability, connectivity, and clinical decision support for emergency healthcare providers.

In April 2026, Zoll Medical advanced its AED and professional defibrillator portfolio with improvements in real-time feedback, data connectivity, and patient care during cardiac emergencies. In January 2026, GE HealthCare advanced cardiac monitoring and defibrillation technologies with greater integration between emergency devices and hospital-care systems.

Click to Read the Complete Insights & Report: https://straitsresearch.com/report/defibrillator-market

Future Outlook

The defibrillator market is expected to expand alongside improvements in cardiac-care infrastructure, public-access AED deployment, portable devices, and connected monitoring systems. Wearable defibrillators, extravascular ICD architectures, remote monitoring, and software-enabled emergency-care technologies are likely to shape product development as manufacturers address the need for faster and more accessible cardiac intervention.

About Straits Research

Straits Research is a global market intelligence and consulting company providing industry research, strategic insights, and customized research solutions across diverse markets. Its research supports businesses, investors, and organizations in evaluating market opportunities, competitive landscapes, and evolving industry trends.